After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Evaluate wide market index fund performance against the SP 500 in retirement planning, emphasizing return consistency and fee impact.
27,720 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
International fans in the World Cup host cities are fueling a new chapter in travel budgets, balancing taste, value, ...
The AI gold rush has turbocharged demand for specialized chips. Morgan Stanley warns of chipflation as hyperscalers i...
Oracle is at a crossroads: AI-enabled cloud growth and savvy capital management could unlock significant upside. Here...
Midsize U.S. firms reduced payments to Chinese suppliers in 2025 as tariff policy remained volatile, signaling a broa...
Instagram will notify parents in its supervision program when their teens search suicide- or self-harm-related terms,...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
A federal judge halted DOJ subpoenas tied to Powell’s June testimony about a $2.5 billion renovation, delivering a se...
In a rapid 48-hour sprint, Congress advanced major child safety bills on both sides of the Capitol, signaling a new e...
Alibaba heads into 2026 with two clear catalysts. This analysis lays out the two big predictions, explains why they c...
Netflix walked away from a blockbuster deal, yet it still raised prices. This personal-finance guide explains what ha...
A CertiK report reveals 34 verified crypto wrench attacks globally, up 41% from last year. Victims’ families are incr...